What You Should Know:
- Tuesday Health, a leader in value-based care for the seriously ill, has launched its innovative supportive care solution with $60M in partnership with Valtruis, Blue Venture Fund, Mass General Brigham Ventures, and CareSource.
- Tuesday Health's mission is to make the end-of-life journey clearer and more supportive for patients and families. With this significant investment and a committed team, they are well-positioned to achieve their goals and
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
SamaCare Secures $17M to Scale Specialty Drug Prior Authorization Platform
What You Should Know:
- SamaCare, a cloud-based patient access platform for specialty medications, today announced that it has closed an oversubscribed $17 million Series B investment round led by new investor Questa Capital.
- Questa is joined in the round by existing investors Vive Collective and South Park Commons.
SamaCare
Read More
Videra Health Secures 5.6M for AI-Powered Mental Health Screening & Monitoring
What You Should Know:
- Videra Health, a frontrunner in AI-powered mental health assessments raises $5.6M in Seed II funding led by Peterson Ventures, with participation from Mercato Partners, Epic Ventures, and Philo Ventures.
- Videra Health aims to tackle these challenges by offering widespread, streamlined mental health screening and monitoring powered by AI technology.
Transforming Mental Health Screening with Video Technology
Videra Health leverages cutting-edge
Read More
Daffodil Health Secures $4.6M for AI-Powered Healthcare Pricing & Admin Solution
What You Should Know:
- Daffodil Health, a healthcare technology company, has secured $4.6M in seed funding to tackle the multi-billion dollar problem of wasted healthcare administrative costs led by Maverick Ventures with participation from Epic Ventures.
- Daffodil Health is the brainchild of a team with over 100 years of combined experience in healthcare and technology, from companies like MultiPlan, Google, and McKinsey. They recognize the urgent need to overhaul the current
Read More
Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption
What You Should Know:
- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and Labcorp, and existing investors, including Health2047.
- The company has also been awarded a $2.3 million Phase II Small Business Innovation Research (SBIR) Grant
Read More
Accenture Backs Turbine’s AI-Powered Platform to Accelerate Drug Discovery
What You Should Know:
- Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
- The investment aims to empower Turbine in extending its innovative technology to global biopharmaceutical companies seeking to unlock hidden biological insights and accelerate crucial drug development processes.
Optimizing Drug Discovery with Simulated
Read More
Medical Nutrition Therapy Startup Fay Emerges from Stealth with $25M
What You Should Know:
- Fay, a San Francisco, CA-based company that focuses on increasing access to medical nutrition therapy emerges from stealth with $25M in funding to tackle America’s growing food crisis.
- The company connects individuals with Registered Dietitians (RDs) for personalized nutrition counseling, all covered by insurance. The insurance-friendly nutrition therapy support platform offers virtual or in-person access to the right RD for individuals’ unique goals
Read More
SmarterDx Nabs $50M for AI-Powered Revenue Integrity for Hospitals
What You Should Know:
- SmarterDx, the leader in clinical AI for revenue integrity and care quality, today announced it has secured $50 million in Series B funding led by Transformation Capital.
- The round also includes continued investments from Bessemer Venture Partners, Flare Capital Partners and Floodgate Fund, bringing total funding to $71 million to date. The investment will drive product
Read More
Brixton Biosciences Secures $33M to Advance Novel Pain Therapies
What You Should Know:
- Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by Schooner Capital with participation from SV Health Investors, Sparta Group, Excelestar Ventures, PV Capital Management, and Catalyst Health Ventures.
- In addition, Brixton has bolstered its leadership team. Dr. Michael Fishman, a renowned pain management specialist, joins as Chief Medical Officer. Additionally,
Read More
Watershed Health Secures $13.6M to Tackle Uncoordinated Care Crisis
What You Should Know:
- Watershed Health, a New Orleans, LA-based provider of real-time care coordination solutions raises $13.6M in funding led by First Trust Capital Partners with participation from FCA Venture Partners, Create Health Ventures, Impact Engine, 450 Ventures, LDH Ventures II/Launchpad Digital Health, MassMutual Ventures, Capstar Partners and Wanxiang Healthcare Investments.
- The investment will fuel the company's mission to combat uncoordinated care, a major
Read More
